XML 55 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 25, 2021
Dec. 31, 2022
Dec. 31, 2021
Disaggregation of Revenue [Line Items]      
Collaboration and license revenue $ 7,500 $ 0 $ 7,500
Lexeo Therapeutics, Inc      
Disaggregation of Revenue [Line Items]      
Collaboration and license revenue $ 7,500